$MDGL: Here’s Why Madrigal Pharmaceuticals Fell 39.4% in November

Date: Saturday, December 8th, 2018

Stock(s) mentioned:

Source: Motley Fool (https://www.fool.com)

Summary: Shares of Madrigal Pharmaceuticals (NASDAQ:MDGL), a clinical-stage biotechnology company, fell 39.4% in November, according to data from S&P Global …

Full article address: https://www.fool.com/investing/2018/12/08/heres-why-madrigal-pharmaceuticals-fell-394-in-nov.aspx

Related News:

$IRWD $MDGL: Analysts Lower Expectations on Pharma Stocks IRWD and MDGL

$MDGL: Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic …

$ICPT $MDGL: Better Buy: Intercept Pharmaceuticals Inc. vs. Madrigal …

$MDGL: Madrigal Pharmaceuticals Presents Buying Opportunity Before Data …

$VKTX $MDGL $SPX $DJIA: Viking Therapeutics stock rose 87% on results for its liver disease drug — and the company has more in store this fall

$MDGL $PFE: 4 Biotech Stocks With Leaky Pipelines

Latest News:

$PF $NWSA: Should You Avoid Pinnacle Foods Inc (PF)?

$OXY: Is Occidental Petroleum Corporation (OXY) A Good Stock To Buy?

$NTR: Hedge Funds Are Crazy About Nutrien Ltd. (NTR)

$NTRS $A: Northern Trust Corporation (NTRS)Hedge Funds Are Snapping Up

$JWN: Why Nordstrom Stock Fell 20% Last Month

$NLSN $LW $ZION: Here is What Hedge Funds Think About Nielsen Holdings plc (NLSN)

$AAL: American Airlines canceled 1100 flights on Sunday, 300 on Monday

$SCCO: Why Shares of Southern Copper Sank 16% in November

$GOOG: ALPHABET 24 HOUR DEADLINE ALERT: Approximately 24 Hours …

$KR $NFLX: Netflix Coughs Up Millions for “Friends”

$RTN $INTU $UBS: Hedge Funds Aren’t Crazy About Raytheon Company (RTN) Anymore